MedTrace Logo

Safety and Effectiveness of Soy Phytoestrogens to Prevent Bone Loss

NCT00665860 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 403

Last updated 2020-11-27

No results posted yet for this study

Summary

The purpose of this study is to determine whether soy isoflavone supplementation is safe and effective to prevent bone loss in postmenopausal women.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

Three pills per day for two years

DIETARY_SUPPLEMENT

Soy isoflavones

Three pills that delivered 80 mg of aglycone isoflavones per day for two years

DIETARY_SUPPLEMENT

Soy isoflavones

Three pills that delivered 120 mg aglycone isoflavones per day for two years

Sponsors & Collaborators

  • University of California

    collaborator OTHER

  • Kaiser Foundation Research Institute

    collaborator OTHER

  • University of Georgia

    collaborator OTHER

  • University of Alabama at Birmingham

    collaborator OTHER

  • Texas A&M University

    collaborator OTHER

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • William W. Wong, Ph.D. · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00665860 on ClinicalTrials.gov